Shaodong Tong

Induction chemoradiotherapy versus induction chemotherapy for potentially resectable stage IIIA (N2) non-small cell lung cancer: a systematic review and meta-analysis.

Zhaohui S. Qin, Z. Qin, Longzhen Zhang, 2018, Journal of thoracic disease.

Effects and mechanisms of GSG2 in esophageal cancer progression

Qiang Wang, Shaodong Tong, Ju-ying Zhou, 2022, Journal of Cancer Research and Clinical Oncology.

Efficacy and safety of anti-PD-1 antibody plus chemoradiotherapy in locally advanced esophageal squamous cancer

Zhaohui Qin, Li-qiang Cui, Jiaying Lu, 2023, Frontiers in Oncology.

Effects and mechanisms of GSG2 in esophageal cancer progression

Qiang Wang, Shaodong Tong, Ju-ying Zhou, 2022, Journal of Cancer Research and Clinical Oncology.

Extensive‐stage small cell lung cancer: Is prophylactic cranial irradiation necessary in the era of immunotherapy with MRI surveillance?

Zhaohui Qin, Li-qiang Cui, Jiaying Lu, 2023, Precision Radiation Oncology.

Anti-programmed death ligand 1 immunotherapy in patients with limited-stage small cell lung cancer: a real-world exploratory study

Zhaohui Qin, Aijun Jiang, Ji Ma, 2022, Journal of chemotherapy.

Effects of brain radiotherapy strategies on survival in the era of MRI for patients with limited stage small cell lung cancer

Jiaying Lu, Shaodong Tong, Na Li, 2024, BMC cancer.